Kellele me abi osutameMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Tunnused
Geeniga CTNNB1 seotud tunnused
catenin beta 1
Inimese fenotüübi ontoloogia seostab geeniga CTNNB1 249 tunnust kehasüsteemide kaupa: omadusi, mida täheldatakse inimestel, kellel on selle geeni üks haruldastest seisunditest.
Kellele me abi osutameMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Kellele me abi osutameMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Abnormality of the nervous system
Abnormality of head or neck
Abnormality of the eye
Abnormality of the endocrine system
Abnormality of the musculoskeletal system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormal deposits of calcium in the brain | Väga sageli (80–99%) |
| Harder, denser, fracture-prone bones | Väga sageli (80–99%) |
| High iliac wing | Väga sageli (80–99%) |
| Increased bone mineral density | Väga sageli (80–99%) |
| Involuntary muscle stiffness, contraction, or spasm | Väga sageli (80–99%) |
| Large iliac wing | Väga sageli (80–99%) |
| Low muscle tone in trunk | Väga sageli (80–99%) |
| Muscular abnormality | Väga sageli (80–99%) |
| Low muscle tone | Sageli (30–79%) |
| Muscle weakness | Sageli (30–79%) |
| Scoliosis | Sageli (30–79%) |
| Asymmetric chest | Mõnikord (5–29%) |
| Breakdown of bone | Mõnikord (5–29%) |
| Ectopic calcification | Mõnikord (5–29%) |
| Increased susceptibility to fractures | Mõnikord (5–29%) |
| Limitation of joint mobility | Mõnikord (5–29%) |
| Low solidness and mass of the bones | Mõnikord (5–29%) |
| Progressive spasticity | Mõnikord (5–29%) |
| Prominent swayback | Mõnikord (5–29%) |
| Spastic diplegia | Mõnikord (5–29%) |
Abnormality of the digestive system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abdominal pain | Väga sageli (80–99%) |
| Abnormality of the abdominal wall | Väga sageli (80–99%) |
| Enlarged liver | Väga sageli (80–99%) |
| Gastrointestinal desmoid tumor | Väga sageli (80–99%) |
| Hepatic fibrosis | Väga sageli (80–99%) |
| Feeding difficulties | Sageli (30–79%) |
| Growths in inner lining of intestine | Sageli (30–79%) |
| Hepatic necrosis | Sageli (30–79%) |
| Malabsorption | Sageli (30–79%) |
| Nausea and vomiting | Sageli (30–79%) |
| Vomiting | Sageli (30–79%) |
| Intestinal obstruction | Mõnikord (5–29%) |
| Poor swallowing | Mõnikord (5–29%) |
| Colon cancer | Pole registreeritud |
| Hepatocellular carcinoma | Pole registreeritud |
| Hereditary nonpolyposis colorectal carcinoma | Pole registreeritud |
| Micronodular cirrhosis | Pole registreeritud |
| Stomach tumor | Pole registreeritud |
| Subacute progressive viral hepatitis | Pole registreeritud |
Abnormality of the integument
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Pilomatrixoma | Alati |
| Abnormal fingernails | Väga sageli (80–99%) |
| Abnormal toenail development | Väga sageli (80–99%) |
| Abnormality of the toenail | Väga sageli (80–99%) |
| Firm lump under the skin | Väga sageli (80–99%) |
| Poor nail formation | Väga sageli (80–99%) |
| Small nail | Väga sageli (80–99%) |
| Underdeveloped toenails | Väga sageli (80–99%) |
| Excessive hair growth | Sageli (30–79%) |
| Excessive sweating | Sageli (30–79%) |
| Stretch marks | Sageli (30–79%) |
| Skin cancer | Mõnikord (5–29%) |
| Itching | Harva (1–4%) |
Abnormality of the cardiovascular system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Avascular peripheral retina | Väga sageli (80–99%) |
| High blood pressure | Sageli (30–79%) |
| Palpitations | Sageli (30–79%) |
| Retinal neovascularization | Sageli (30–79%) |
| Disruption of blood oxygen supply to brain | Mõnikord (5–29%) |
| Macular exudate | Mõnikord (5–29%) |
| Macular telangiectasia | Mõnikord (5–29%) |
| Narrowing of aorta | Mõnikord (5–29%) |
| Narrowing of aortic valve | Mõnikord (5–29%) |
| Heart attack | Harva (1–4%) |
Growth abnormality
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Mild short stature | Väga sageli (80–99%) |
| Increased body weight | Sageli (30–79%) |
| Obesity | Sageli (30–79%) |
| Weight loss | Sageli (30–79%) |
| Growth delay | Mõnikord (5–29%) |
| Proportionate short stature | Mõnikord (5–29%) |
| Severe short stature | Mõnikord (5–29%) |
| Small for gestational age | Mõnikord (5–29%) |
| Growth delay as children | Harva (1–4%) |
Abnormality of the genitourinary system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormality of reproductive system physiology | Sageli (30–79%) |
| Abnormality of the upper urinary tract | Mõnikord (5–29%) |
| Hydronephrosis | Mõnikord (5–29%) |
| Cancer starting in small tubes in kidneys | Pole registreeritud |
| Dysgerminoma | Pole registreeritud |
| Ovarian papillary adenocarcinoma | Pole registreeritud |
| Transitional cell carcinoma of the bladder | Pole registreeritud |
| Uterine leiomyosarcoma | Pole registreeritud |
Laboratory abnormality
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Elevated circulating alpha-fetoprotein concentration | Väga sageli (80–99%) |
| Diabetes mellitus | Sageli (30–79%) |
| High urine cortisol level | Sageli (30–79%) |
| Laboratory abnormality | Sageli (30–79%) |
| Low blood potassium levels | Sageli (30–79%) |
| Noninsulin-dependent diabetes | Mõnikord (5–29%) |
| Pee issues | Mõnikord (5–29%) |
| Swelling caused by excess lymph fluid under skin | Mõnikord (5–29%) |
Abnormality of limbs
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormality of the wide portion of a long bone | Väga sageli (80–99%) |
| Coarse metaphyseal trabecularization | Väga sageli (80–99%) |
| Extra little finger | Väga sageli (80–99%) |
| Curvature of little finger | Sageli (30–79%) |
| Overlapping fingers | Sageli (30–79%) |
| Small hand | Sageli (30–79%) |
| Broad finger | Mõnikord (5–29%) |
Abnormality of the ear
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Abnormal antihelix morphology | Sageli (30–79%) |
| Conductive deafness | Sageli (30–79%) |
| Ears rotated toward back of head | Mõnikord (5–29%) |
| Hearing impairment | Mõnikord (5–29%) |
| Low-set ears | Mõnikord (5–29%) |
| Dizziness | Harva (1–4%) |
Constitutional symptom
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Epigastric pain | Sageli (30–79%) |
| Fatigue | Sageli (30–79%) |
| Muscle ache | Sageli (30–79%) |
| Chest pain | Mõnikord (5–29%) |
| Joint pain | Mõnikord (5–29%) |
Abnormality of blood and blood-forming tissues
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Blood clot in portal vein | Sageli (30–79%) |
| Gastrointestinal bleeding | Mõnikord (5–29%) |
| Vitreous hemorrhage | Mõnikord (5–29%) |
Abnormality of the immune system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Infection in blood stream | Mõnikord (5–29%) |
| Anti-myeloperoxidase antibody positivity | Harva (1–4%) |
| Recurrent infections | Harva (1–4%) |
Abnormal tissue mass
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Fibroma | Väga sageli (80–99%) |
| Head and neck tumor | Väga sageli (80–99%) |
Abnormality of the breast
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Breast cancer | Pole registreeritud |
Abnormality of the respiratory system
| Tunnus | Kui sageli seda täheldatakse |
|---|---|
| Lung adenocarcinoma | Sageli (30–79%) |
Kui sageli see esineb geenist tulenevate seisunditega inimeste seas, kõige sagedamini nende kõigi seas, nagu on märgitud Inimese fenotüübi ontoloogias. Need lehed kirjeldavad tunnuseid ja nende taga olevaid uuringuid; need ei ole diagnoos ning sümptomite kohta tuleks küsida arstilt või geneetilt nõustajalt.
Allikas
- Inimese fenotüübi ontoloogia, versioon 2026-09-01: geeniga CTNNB1 seotud tunnused ja iga tunnuse esinemissagedus. Lisateavet leiate aadressilt hpo.jax.org.
Kellele me abi osutameMeie teadusTootedTulemused
Logi sisseKüsiSekveneeri oma genoom↗
Üks test. Vastused kogu eluks.
Alates 449 $Tasuta kohaletoimetamine · Tulemused 6–8 nädala pärast